INS and diabetes mellitus: However, in selected high-risk patients—such as those with neurotrophic dysfunction, diabetes mellitus, delayed healing beyond 72 h, persistent epithelial defects, or ocular surface instability—topical insulin may offer clinically meaningful benefit and warrants further investigation in larger controlled cohorts [2].